Position in TNGX
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$16,906,560
+$12,361,070 QoQ
Shares Held
808,153
+57.5% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,580,660,548 across 68 Biotechnology names. TNGX ranks #48 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in TNGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,906,560 | 808,153 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $4,545,490 | 513,035 | Shares | Sole | 2026-02-17 | |
| 2023-12-31 | $11,007,513 | 1,111,870 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $27,237,579 | 2,418,968 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||